EGFR and non-small cell lung carcinoma: Meta-analysis was therefore urgently needed to systematically assess the quality of available evidence and make a scientific conclusion about WBRT plus EGFR-TKIs compared with EGFR-TKIs alone and WBRT alone in treating BM from NSCLC.